Abstract
Executive Summary
BioSeeker Group have identified 165 companies plus partners who are today
developing 200 drugs targeting renal cancer in development. Across 172
different targets. In addition, there are 4 suspended drugs and another 60
drugs where development has been ceased.
For busy executives within Pharma, Biotech and Investment companies who know
they need to stay on top of the developmental environment in their field, we
offer the Drug Pipeline update series.
You get detailed, world-wide drug pipeline information, delivered in an
unbiased and independent pipeline progress analysis for each identified drug.
Buying the Renal Cancer Drug Pipeline Update 2012 will mean you have this
important data at your fingertips and ensure that you can:
- Show investors/board/management that you are right on top of drug
development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc. and track
them by their products.
- Jump start competitive drug intelligence operations
- Benchmark your own development against world wide data
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/outlicensing strategy work
Some facts about Renal Cancer Drug Pipeline Update 2012
The high existing unmet need in the treatment of renal cancer is reflected by
the poor prognosis of patients with advanced stage disease, fiveyear survival
rates with existing cytokine therapy being less than 20% (RCC) in this patient
cohort.The identification of biomarkers is set to revolutionize patient
staging and prognosis by individualizing patient treatments and creating novel
drug targets.
There are today 165 companies plus partners developing 200 drugs targeting
renal cancer in development. In addition, there are 4 suspended drugs and the
accumulated number of ceased drugs over the last years amount to another 60
drugs. Renal Cancer Drug Pipeline Update lists all drugs and gives you a
progress analysis on each one of them. Identified drugs are linked to 172
different targets. These targets are further categorized on in the software
application by 45 classifications of molecular function and with pathway
referrals to BioCarta, KEGG and NetPath.
Table of Contents
Details from Renal Cancer Drug Pipeline Update 2012 at a glance
This short overview shows actual findings from the Renal Cancer Drug Pipeline
Update 2012 report.
Investigators
Includes more than 165 principal investigators plus their collaborators. There
is direct access from inside the application to web pages of all principal
investigators.
Note: You are able to sort and find drugs according to investigators and
partners from drop-down menus in the application. You may also sort and find
drugs according to country of investigator.
Drug name & Synonyms
Lists commercial, generic and code names for drugs.
Developmental stage
This Drug Pipeline Update contains 200 drugs in development for the treatment
of renal cancer. In addition there are suspended and ceased drugs.
Pipeline Breakdown According to Number of Drugs
- Marketed# 24
- Registered# 1
- Pre-registration# 2
- Phase III# 7
- Phase II# 76
- Phase I# 62
- Preclinical# 28
- Suspended# 4
- Ceased# 60
Note: You are able to sort and find drugs according to developmental stage
from drop-down menu in the application.
Indications
Included renal cancer drugs are also in development for 180 other indications,
where of 80 are different cancer indications.
Note: You are able to find and sort drugs according to type of indication from
drop-down menu in the application.
Targets
Identified drugs are linked to more than 172 different targets, divided into
45 classifications of molecular function:
- Carboxy-lyase activity
- Carboxypeptidase activity
- Catalytic activity
- Cell adhesion molecule activity
- Complement activity
- Cysteine-type peptidase activity
- Cytokine activity
- DNA binding
- DNA topoisomerase activity
- DNA-directed DNA polymerase activity
- DNA-methyltransferase activity
- Extracellular matrix structural constituent
- G-protein coupled receptor activity
- Glutathione transferase activity
- Growth factor activity
- Hydrolase activity
- Kinase activity
- Kinase regulator activity
- Ligase activity
- Lipid kinase activity
- Lipid phosphatase activity
- Molecular function unknown
- Motor activity
- Oxidoreductase activity
- Peptide hormone
- Phosphoric diester hydrolase activity
- Protein binding
- Protein serine/threonine kinase activity
- Protein threonine/tyrosine kinase activity
- Protein tyrosine phosphatase activity
- Protein-tyrosine kinase activity
- Receptor activity
- Receptor binding
- Receptor signaling complex scaffold activity
- RNA binding
- RNA-directed DNA polymerase activity
- Structural constituent of cytoskeleton
- Superoxide dismutase activity
- T cell receptor activity
- Transcription factor activity
- Transcription regulator activity
- Translation regulator activity
- Transmembrane receptor activity
- Transmembrane receptor protein tyrosine kinase activity
- Transporter activity
Identified targets are categorized into 22 different primary and alternate
sub-cellular localizations:
- Cell surface
- Centrosome
- Clathrin-coated vesicle
- Cytoplasm
- Cytoplasmic vesicle
- Cytoskeleton
- Cytosol
- Endoplasmic reticulum
- Endosome
- Extracellular
- Golgi apparatus
- Integral to membrane
- Lysosome
- Microtubule
- Mitochondrion
- Nucleolus
- Nucleus
- Perinuclear region
- Perinuclear vesicle
- Plasma membrane
- Secretory granule
- Secretory vesicle
Note: You are able to find and sort drugs according to target gene name,
molecular function of target, and target localization from drop-down menus in
the application.
Target Expression Profile
Direct links are provided from inside the application to 234 protein
expression profiles of 147 drug targets in various human tissues and cancer
types, cell lines and primary cells, including up to:
- 48 different normal tissue types
- 20 different types of cancer
- 47 cell lines
- 12 samples of primary blood cells
Pathway Referals
Identified targets have been cross referenced against their involvement in
different cellular pathways, according to BioCarta, KEGG and NetPath.
- BioCarta# 211 Pathways
- KEGG# 149 Pathways
- NetPath# 25 Signaling Pathways
Note: You are able to find and sort drugs according to targeted pathways from
drop-down menus in the application.
Mechanism
In total there are different drug mechanism of action represented in this Drug
Pipeline Update.
Note: You are able to find and sort drugs according to mechanism of action
from drop-down menu in the application.
Compound
Identified drug compounds are described by:
- Compound type, Chemical name, CAS Number and molecular weight
Note: You are able to sort and find drugs according to compound type from
drop-down menu in the application.
The Drug Profiles: Progress analysis and review of drug development.
Renal Cancer Drug Pipeline Update 2012 provides you with a profile for each
identified drug. A typical drug profile reports on, depending on stage of
development and available information:
Drug Name & Synonyms
Presentation of drug name and synonyms.
Principal Investigator & Partners
Presentation of principal investigator and partners.
Target and Molecular Function of Target
Described target(s) is/are presented with:
- Official Gene Symbol - Official Gene Name [Species/Homo Sapiens] -
Molecular Function
Target Localization
Described target(s) is/are presented with primary and alternate localizations.
Target Expression Profiles
Links to protein expression profile(s) of target(s) in various human tissues,
cell lines and primary cells, including up to:
- 48 different normal tissue types
- 20 different types of cancer
- 47 cell lines
- 12 samples of primary blood cells
Targeted Pathways
Described target(s) is/are matched for the involvement in cellular pathways
according to BioCarta, KEGG, and NetPath.
Mechanism
Drug mechanism of action
Developmental Projects
Summary field of developmental projects for the drug, including indication,
developmental stage and status.
Example:
- Cancer, myeloma - Phase II Clinical Trial - Active
- Cancer, prostate - Phase III Clinical Trial - Ceased
Drug Description
Short introduction to drug
Compound Data
Compound type, Chemical name, CAS Number and molecular weight.
Patent Data
Available patent information related to the drug is presented here.
Analysis
- Business & Markets
- Collaborations and deals
- Approvals and submissions
- Analyst comments
Phase III Data
Available Phase III development data, developmental history and scientific
data.
Phase II Data
Available Phase II development data, developmental history and scientific data.
Phase I Data
Available Phase I development data, developmental history and scientific data.
Preclinical Data
Available preclinical development data, developmental history and scientific
data.
Licensing Information
Availability for licensing.
About the unique Drug Pipeline Update Software Application
After purchase, the Drug Pipeline Update is delivered to you via electronic
download in a powerful yet easy to use desktop application which requires no
installation.
Find and sort drugs by twelve different parameters plus free text search
field. Our dynamic report generator lets you easily and quickly generate HTML
drug profile reports directly in your web browser, whether it is a single drug
profile or your own report selection of drugs that match your criteria.
Application Features
Use 13 different parameters, available in drop-down menus, to find and sort
among drugs
- Drug status
- Clinical Trial Status
- Principle Investigator
- Partners
- Indication
- Developmental Stage
- Compound Type
- Mechanism
- Target
- Molecular Function of Target
- Target Localization
- Targeted Pathways
- Free text search of entire drug profile contents
Direct linkage from inside the application to related internet resources
- Drug data is linked to search engines like Google and PubMed
- Drug target data is linked directly to BioCarta, Human Protein Atlas,
KEGG, and NetPath
- Direct links to company web pages of principal investigators
Dynamic Report Generator
Our dynamic report generator lets you with ease and speed generate html
reports directly in your web browser (Internet Explorer), whether it is a
single drug profile or an entire search you want have a report of.
System Requirements
- Operating system: Windows (2000/XP/Vista/7) and Mac OS X 10.6 (Snow
Leopard) and OS X 10.7 (Lion)
- Browser Application (Internet Explorer)
- Internet access (to access related internet resources)
Renal Cancer Drug Pipeline Update 2013 published by BioSeeker Group AB in April 22, 2013. This report price starts from US $ 2249.
The contents of this page may be different from the latest version. Please contact us for details.
